News

Highlights Semaglutide medications like Ozempic may cause facial changes. You can take steps to help minimize or prevent ...
Lebanon: A recent study analyzing data from the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) has ...
For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy.
A YOUNG woman has revealed that she lost over six stone on Mounjaro but has noticed some very strange side effects. Foxy, a singer and musician from the UK, was able to slim down and lose 6 stone ...
New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that women are much more aware of knowledgeable about the obesity drugs GLP-1/GIP ...
Tirzepatide (Mounjaro) launched in India in March 2025, promising new hope for diabetes and obesity treatment. An expert ...
HealthDay News — The rate of emergency department visits for adverse events among patients dispensed semaglutide is low, with most visits involving gastrointestinal effects, according to a research ...
Researchers found that by December 2023, more than 1 in 3 of the medications being started for type 2 diabetes treatment were GLP-1RA-based medications.
In summary, GLP-1 receptor agonists, originally used to treat diabetes, are now being explored for brain protection. Two ...
A MOTHER has revealed that she lost seven stone after using Mounjaro.  Kellie Willey, a make-up and fashion fan from the UK, ...
With Semaglutide, postmenopausal women can achieve significant weight loss, improve insulin sensitivity, and lower the risk ...
A recent survey reveals the foods that people are less likely to eat once they start taking GLP-1 medications like Ozempic.